Catalyst Wire Dossier Catalyst Wire Dossier

AAV2-hAADC

AAV2-hAADC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AAV2-hAADC, covering 2023-02-10 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: AAV2-hAADC for Parkinson's Disease (PDCS-01) [Phase 1]

See pricing